Portfolio: Investments

Nevro Corp.
Nevro is developing neuromodulation therapies for multiple indications

Oxagen Limited
Small molecule drugs for inflammatory and respiratory diseases

Pacira Pharmaceuticals, Inc.
Sustained-release drug delivery technologies

Pharmathene, Inc.
Biotherapeutics targeting bioterrorism

Poniard Pharmaceuticals, Inc.
Innovative oncology products

Portola Pharmaceuticals, Inc.
Next generation anti-thrombotic drugs